Compliances -Certificate under Reg.74(5) of SEBI.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Transgene Biotek Ltd has submitted a quarterly compliance certificate under SEBI Regulation 74(5) for the period October 1, 2025 to December 31, 2025. The certificate was issued by the company's Registrar and Share Transfer Agent (RTA), Bigshare Services Private Limited, confirming that all share dematerialization and rematerialization requests received from NSDL and CDSL during the quarter were duly processed. The RTA further confirmed that physical certificates received for dematerialization were mutilated and cancelled after verification, and the depository names were updated as registered owners in the company's member register within the stipulated 15-day period. The filing was signed by Dr K Koteswara Rao, Managing Director.
This is a routine quarterly regulatory compliance filing with no material impact on the company's business, financials, or share price. It simply confirms the proper processing of demat/remat requests by the RTA during the quarter, indicating standard administrative adherence to SEBI norms.